About the PDAB
MYTH VS. FACT
RESOURCES
SIGN UP

Resources

NEWS

Maryland’s Prescription Drug Affordability Board Has Failed to Lower Costs
Baltimore Sun
Why ending New Hampshire’s PDAB was the right move for patients
Concord Monitor
Judge temporarily blocks Colorado’s first-in-the-nation price cap on a prescription drug
Colorado Sun
In Maryland, drug price controls won’t help patient affordability
Maryland Matters
Audit Finds $1.4 Million In Unpaid Fees At Maryland Prescription Drug Affordability Board
BayNet
It’s Time to Hit Pause on the PDAB
Maryland Matters
PDABs Fail to Account for the Complexities of Patient Access to Therapies
Center Maryland

VIDEOS

REPORTS

Specialist Physicians’ Perspectives on State PDABs: Access, Affordability, and Administrative Burden
Magnolia Market Access
Follow the Upper Payment Limit
Rare Access Action Project
Biotech and Life Sciences Update in Maryland
Maryland Tech Council
Upper Payment Limits on Drugs Could Alter Patient Access
Avalere Health
The U.S. Biopharmaceutical Innovation Ecosystem at Risk: The 20-Year Threat to U.S. Innovation and Cures
Magnolia Market Access
Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main Street Pharmacies
Federal Trade Commission